# Sources — John Locke

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

Accessed November 6, 2026. The canonical source metadata and claim links are in `case.json`.

## Historical evidence

1. Uzgalis W. “John Locke.” *The Stanford Encyclopedia of Philosophy* (substantive revision July 7, 2022). Supports that he “was born in Wrington to Puritan parents of modest means”, that his father “was a country lawyer who served in a cavalry company on the Puritan side”, Westminster School and Christ Church, Oxford (autumn 1652), his BA in February 1656, his medical studies and research with Sydenham, the Bachelor of Medicine and “a license to practice medicine” in 1674, his exile in Holland and return in February 1689, residence at Oates “the home of Sir Francis and Lady Masham (Damaris Cudworth)”, that during his years on the Board of Trade “Locke was asthmatic, and he suffered so much from it that he could only bear the smoke of London during the four warmer months of the year”, and that he “remained in retirement at Oates until his death on Sunday 28 October 1704”. https://plato.stanford.edu/entries/locke/
2. Stephen L. “Locke, John (1632-1704).” *Dictionary of National Biography*, vol. 34 (1893), on Wikisource. Born “29 Aug. 1632, at Wrington, Somerset”; his mother Agnes Keene and brother Thomas (born 1637); his father's death on 13 Feb. 1660-1 and “Thomas's death from consumption soon afterwards”; election to Christ Church at Whitsuntide 1652; the M.B. in 1674 and no doctorate; “In 1668 he performed an operation for an internal abscess, from which Ashley suffered”; his “close friendship with Thomas Sydenham”; “His health was already weak” and Sydenham's letter of about 1674 advising him “to go to bed early and be very temperate and cautious”; Montpellier, “then frequently visited by invalids”; leaving England in the autumn of 1683 and landing at Greenwich 12 Feb. 1688-9; declining a mission “on the ground of insufficient health”; “He found the smoke of London unfavourable to his health, and from the spring of 1691 became domiciled at Oates, in the parish of High Laver, Essex”; the Board of Trade and confinement to Oates outside summer and autumn; the summons of 23 Jan. 1697-8; “gradually failing health”; his death on 28 Oct. 1704 while Lady Masham read the psalms, and burial in the churchyard at High Laver. https://en.wikisource.org/wiki/Dictionary_of_National_Biography,_1885-1900/Locke,_John_(1632-1704)
3. Fox Bourne HR. *The Life of John Locke*, vol. 1 (London: Henry S. King, 1876). Internet Archive. His father “died of consumption, or some kindred malady, at the comparatively early age of fifty-four; and his only brother died also of consumption when he was only about six-and-twenty”; the undated fragment “Tussis” and “As Locke began about this time to have a cough that seriously troubled him through the remainder of his life”; Lady Masham's account (to Le Clerc, 12 Jan. 1704-5) that after his return from France he could not stay long in London without retreating “to recover the prejudice his health received from the smoke of that vast quantity of sea-coal which is burnt in this great city”; Fox Bourne's judgment that the malady “probably, only extreme care in the treatment of himself had prevented from passing into a rapid consumption”; and the account of phthisis in Locke's “Extracts of Sydenham's Physic Books”, attributing the frequency of consumptions in London to “a perpetual mist” and “especially the sulphur and fumes of sea coals, with which the air is repleted; and these being sucked into our lungs, and insinuated into the blood itself, give an occasion to a cough”. https://archive.org/details/lifeofjohnlocke01bouruoft
4. Fox Bourne HR. *The Life of John Locke*, vol. 2 (1876). Internet Archive. Locke to Limborch, 12 April 1689 (hoping “to be able to breathe more easily, and to be less troubled by my cough”); to Limborch, 29 Feb. 1691-2 (“my health has kept me in the country, for I found my lungs could not bear the smoke of the city”); Newton to Locke, 3 May 1692 (“Now the churlish weather is almost over”), and his day or two at Cambridge; to Limborch and to Clarke, 28 Nov. 1692 (“after a single day's stay there I fell so ill that I could hardly breathe”; “well I cannot say I yet am, under so troublesome a cough as I have, but my lungs move easier than they did”); to Somers after the king's summons of January 1697-8 (“when I was laid in my bed, my breath failed me. I was fain to sit up in my bed … at three I got up, and sat by the fire till morning”); to Limborch, 18 Oct. 1698 (“A troublesome cough and great difficulty of breathing urge my departure”); the sore legs of 1700 and 1701 and “my old evil of my breast”; his deafness in 1702; to Peter King, 1 June 1704 (“my shortness of breath and uneasiness every day increases”); the swelling of his legs that summer, from Le Clerc's éloge; and Lady Masham's “his weakness, of which only he died”. https://archive.org/details/lifeofjohnlocke02bouruoft
5. Williams AN. “Physician, philosopher, and paediatrician: John Locke's practice of child health care.” *Arch Dis Child* 2006;91(1):85-89. PMID 16371386. “John Locke … was born in Wrington, Somerset on 29 August 1632”; “He finally received his BM degree on 6 February 1675”; “Sometime in 1667 John Locke met Thomas Sydenham and embraced his medical ideas”; “Throughout his life, Locke's health was blighted by asthma, which often incapacitated him for long periods”; his last years at Oates, where “He died there on 28 October 1704”. https://pmc.ncbi.nlm.nih.gov/articles/PMC2083071/
6. Anstey PR, Principe LM. “John Locke and the case of Anthony Ashley Cooper.” *Early Sci Med* 2011;16(5):379-503. PMID 22332471. In June 1668 Ashley “underwent abdominal surgery to drain a large abscess above his liver”, with case notes in Locke's hand and advice from physicians including Thomas Sydenham. https://pubmed.ncbi.nlm.nih.gov/22332471/
7. Longstaff A. *Calendars from around the world.* Royal Museums Greenwich. The Gregorian reform removed ten days; Britain adopted the Gregorian calendar only in 1752. https://www.rmg.co.uk/sites/default/files/Calendars-from-around-the-world.pdf
8. HISTMED Master Roster v3. Internal project source. Its entries were provisional and were not treated as independent corroboration.

## Clinical guidance

1. CMID: Clinical Monitoring Intelligence Database (Aether Forge, 2026), asthma and COPD monographs. Review 1 to 3 months after starting or changing controller treatment, then every 3 to 12 months, and within 1 week of any exacerbation; ACT or ACQ, inhaler technique, adherence, reliever use, trigger and pollution exposure review, and the action plan at every visit; spirometry at diagnosis, 3 to 6 months after stabilization, then every 1 to 2 years; FeNO and eosinophils for diagnostic uncertainty and phenotyping; imaging only for atypical features; comorbidity surveillance at diagnosis and yearly; pulmonary rehabilitation for persistent breathlessness; biologic assessment only when severe and uncontrolled. https://patrickrutledge.github.io/topthirty/
2. Global Initiative for Asthma. *Global Strategy for Asthma Management and Prevention*, 2025 update. Track 1 ICS-formoterol as maintenance and reliever, no SABA-only treatment, add-on LAMA at steps 4 to 5, written action plans, and the advice that patients with features of asthma and COPD receive inhaled corticosteroid. https://ginasthma.org/reports/
3. National Asthma Education and Prevention Program. *2020 Focused Updates to the Asthma Management Guidelines.* J Allergy Clin Immunol 2020;146(6):1217-1270. PMID 33280709. FeNO as an adjunct for diagnostic uncertainty; SMART at steps 3 and 4; impairment classification (FEV1 60 to 80 percent predicted in moderate persistent asthma). https://pubmed.ncbi.nlm.nih.gov/33280709/
4. Global Initiative for Chronic Obstructive Lung Disease. *2025 GOLD Report.* Post-bronchodilator FEV1/FVC below 0.70; non-tobacco causes including household solid-fuel smoke and ambient air pollution; alpha-1 antitrypsin screening. https://goldcopd.org/2025-gold-report/
5. Stanojevic S, et al. “ERS/ATS technical standard on interpretive strategies for routine lung function tests.” *Eur Respir J* 2022;60(1):2101499. PMID 34949706. Lower limits of normal and a bronchodilator response of more than 10 percent of the predicted value. https://pubmed.ncbi.nlm.nih.gov/34949706/
6. Bhakta NR, et al. “Race and Ethnicity in Pulmonary Function Test Interpretation: An Official American Thoracic Society Statement.” *Am J Respir Crit Care Med* 2023;207(8):978-995. PMID 36973004. GLI Global race-neutral equations. https://pubmed.ncbi.nlm.nih.gov/36973004/
7. Rochester CL, et al. “Pulmonary Rehabilitation for Adults with Chronic Respiratory Disease: An Official American Thoracic Society Clinical Practice Guideline.” *Am J Respir Crit Care Med* 2023;208(4):e7-e26. PMID 37581410. Its recommendations cover COPD, interstitial lung disease, pulmonary hypertension, and delivery models; it is cited for program delivery, while the indication in asthma rests on GINA and the CMID. https://pubmed.ncbi.nlm.nih.gov/37581410/
8. World Health Organization. *WHO global air quality guidelines: particulate matter (PM2.5 and PM10), ozone, nitrogen dioxide, sulfur dioxide and carbon monoxide* (2021). PM2.5 guideline levels of 5 ug/m3 (annual mean) and 15 ug/m3 (24-hour mean), as tabulated in the UK Committee on the Medical Effects of Air Pollutants' response to the guidelines. https://www.who.int/publications/i/item/9789240034228
9. Carlsten C, Salvi S, Wong GWK, Chung KF. “Personal strategies to minimise effects of air pollution on respiratory health: advice for providers, patients and the public.” *Eur Respir J* 2020;55(6):1902056. PMID 32241830. “Qualified evidence supports limiting physical exertion outdoors on high air pollution days and near air pollution sources, reducing near-roadway exposure while commuting, utilising air quality alert systems to plan activities, and wearing facemasks in prescribed circumstances”, and “avoiding cooking with solid fuels … and using portable air cleaners fitted with high-efficiency particulate air filters”. https://pubmed.ncbi.nlm.nih.gov/32241830/
10. U.S. Environmental Protection Agency. *AQI Basics* (AirNow): 101 to 150 is “Unhealthy for Sensitive Groups”. https://www.airnow.gov/aqi/aqi-basics/ ; and *Air Cleaners and Air Filters in the Home*. https://www.epa.gov/indoor-air-quality-iaq/air-cleaners-and-air-filters-home
11. Harris AM, et al. “Appropriate Antibiotic Use for Acute Respiratory Tract Infection in Adults.” *Ann Intern Med* 2016;164(6):425-434. PMID 26785402. https://pubmed.ncbi.nlm.nih.gov/26785402/
12. Medicare Preventive Services reference (Aether Forge, 2026); CDC Adult Immunization Schedule by Age (2026), including RSV vaccination for adults 60 to 74 at increased risk (chronic lung disease); and U.S. Preventive Services Task Force recommendations on colorectal cancer screening (2021), depression screening (2023), statin use (2022), prostate cancer screening (2018), and lung cancer screening (2021). https://patrickrutledge.github.io/preventative_services/ and https://www.cdc.gov/vaccines/hcp/imz-schedules/adult-age.html and https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer-screening

## Editorial resolutions

- **Calendar and dates.** England used the Julian (Old Style) calendar throughout his life, with the legal year beginning on 25 March. He was born on 29 August 1632 (Julian), which is 8 September 1632 in the Gregorian calendar, and died on 28 October 1704 (Julian), which is 8 November 1704 (Gregorian); the difference was ten days until February 1700 and eleven after. Every documented date is converted to the Gregorian calendar for the true frame, checked by computing Julian day numbers in the build script; the preferred birth and death dates are Gregorian, with the Julian dates recorded as superseded alternatives, and timeline displays give both. Years written “1691-2” in the sources are given as 1691/2 (Julian) and their Gregorian equivalent. Fox Bourne's dates for letters written from Oates are taken as Julian; Limborch, in Amsterdam, may have dated his own letters in the Gregorian calendar, and none of his dates is used.
- **Index age and dates.** The episode presents him at 59, at Oates, in March 1692, two days after his documented letter of 29 February 1691/2 (Julian; 10 March 1692, Gregorian) saying that his lungs could not bear the smoke of the city. The synthetic date of birth is September 8, 1966, so the whole-year shift is 334 years and 2026 maps to 1692. The visits are March 12 (index), March 26 (diagnosis and consultation), June 18 (twelve-week review), September 17 (preventive visit, at 60), October 8 (sick visit), and October 22, 2026; in the true frame these fall between 12 March and 22 October 1692 (Gregorian), all within his lifetime, while he lived at Oates. His documented visit to Cambridge in May 1692 falls between visits, and his documented London trip of late November 1692 falls after the episode. He is 59 at the first three visits and 60 at the last three.
- **Name and mentions.** “John Locke” splits simply into given and family names, so `identity.name_parts` is not used, and no alias is recorded. Isaac Newton (HR-EN011) is named in one documented claim (his letter of 3 May 1692 inviting Locke to Cambridge), so HR-EN011 is listed in `identity.historical_mentions`; the modern episode does not name him.
- **What was verified and what was not.** His lifelong cough from about 1670, his intolerance of London's coal smoke, his move to Oates in the spring of 1691, his letters about his lungs and breathing (1689 to 1704), the breathlessness lying flat of January 1698, the sore legs and deafness of his last years, the leg swelling and increasing breathlessness of 1704, and his death are **D**, from the Dictionary of National Biography, the Stanford Encyclopedia of Philosophy, Williams (2006), and Fox Bourne's biography, which quotes his letters and Lady Masham's account; letters written in Latin are quoted in Fox Bourne's translation. The de Beer edition of the correspondence, Woolhouse's biography, Dewhurst's medical biography, Cohen's 1995 article, the Bodleian Locke manuscripts, and the 1932 *Canadian Medical Association Journal* article (a scanned image only) could not be read and are not cited. No medical notes in which Locke described his own illness were found; Fox Bourne states that the “Tussis” fragment contains no personal information, and the record says so.
- **Corrections to the roster.** The roster says that asthma and probable tuberculosis drove him into exile in the Netherlands for cleaner air. The sources read describe the exile of 1683 to 1689 as political, so the record does not say he went abroad for his health; his journey to Montpellier in 1675 is the documented health journey. The roster's “tuberculosis” is not supported: no source read diagnoses it; his father and brother died of “consumption”, recorded as family history, and Fox Bourne's view that care kept his cough from passing into consumption is **R**, possible (CLM-0019). The roster's “insomnia” and “political exile stress” were not found in the sources read and are left out.
- **Asthma as a historical diagnosis.** That he was “asthmatic” comes from modern secondary sources (the Stanford Encyclopedia and Williams), not from a physician of his time, and is recorded as **R**, probable (CLM-0018). Fox Bourne uses the word asthma only of the king. The breathlessness lying flat and the leg swelling of his last years are recorded as documented symptoms; the record proposes no historical diagnosis of heart failure or any cause of death, because no source read offers one.
- **Presenting problem and diagnosis.** The intake problem (R05.3) is a chronic cough with wheeze and breathlessness, resolved on March 26, 2026, when asthma with persistent airflow limitation is recorded. The diagnosis was chosen between asthma with persistent airflow limitation and COPD from non-tobacco exposures, and decided for asthma: onset in his late thirties, variation with season, cold, and smoke, a bronchodilator response of 380 mL (11 percent of predicted), FeNO 41 ppb, eosinophils 0.46 x 10^3/uL, a raised IgE, a normal DLCO, and a CT without emphysema; the post-bronchodilator ratio below 0.70 and the lifelong exposures are why COPD was considered. The record follows GINA and GOLD in treating anyone with asthma features as asthma, with inhaled corticosteroid. The ICD-10-CM code is J45.40 (moderate persistent) because his pre-bronchodilator FEV1 of 62 percent predicted falls in the NAEPP moderate band; it is placed both_with_link to the documented history.
- **Spirometry and results.** All results are synthetic. Spirometry is interpreted with GLI Global race-neutral equations (ATS 2023) and the ERS/ATS 2022 bronchodilator criterion; the predicted values and lower limits were estimated for a man of 59 and 178 cm and are stated in each reference range. FEV1 percent predicted is coded with LOINC 20152-5 as measured before bronchodilator. The CT and chest X-ray are recorded as procedures with their findings, because their results are not numeric.
- **Exposure and its modern form.** The modern exposure (about 30 years in a large city near main roads, then open coal and wood fires in his rooms) echoes, without measuring, the coal smoke that he, Sydenham, and Lady Masham blamed for his cough (CLM-0007, CLM-0008). The exposure advice follows the ERS 2020 personal-strategies paper, the WHO 2021 air quality guidelines (PM2.5 5 ug/m3 annual, 15 ug/m3 24-hour, verified in the UK COMEAP table because the WHO pages show the values only as images), the AirNow AQI categories, and the EPA guide to air cleaners. The household that removes the open fires is synthetic and unnamed.
- **Treatment choices.** Albuterol alone for two weeks only, so the bronchodilator response could be measured before an inhaled corticosteroid; then medium-dose budesonide-formoterol as maintenance and reliever (GINA track 1, step 4) because asthma was very poorly controlled with low lung function; at twelve weeks, with an Asthma Control Test of 19, persistent airflow limitation, good adherence, and FeNO down to 22 ppb, add-on tiotropium (GINA step 5) rather than a higher corticosteroid dose; no biologic, because he has had no flares needing oral corticosteroids. Pulmonary rehabilitation improved his six-minute walk by 75 m.
- **Tuberculosis and other exclusions.** Because of a chronic cough and his family history of consumption, an interferon-gamma release assay and a chest X-ray are done and are negative. Alpha-1 antitrypsin deficiency (GOLD) and heart failure (NT-proBNP) are excluded at intake.
- **Sick and preventive visits.** The preventive visit is `preventive_adult` because he is 60; it gives influenza, COVID-19, and RSV vaccines (RSV recommended at 60 to 74 with chronic lung disease), defers zoster to the next visit at his request (given at the last visit), screens lipids (normal), records that he declined PSA screening after a shared decision, and documents advance care planning that names no real person. The sick visit is a common cold with a yellow-zone flare (peak flow 68 percent of best), managed by his action plan with extra budesonide-formoterol and no oral corticosteroid or antibiotic, with explicit thresholds for prednisolone and for emergency care; it echoes, without asserting, his documented autumn chest troubles.
- **Focused visits.** The three chronic-care follow-ups (two weeks, twelve weeks, and seven months after intake) are documented as focused visits on the CMID asthma and COPD monographs with GINA 2025, NAEPP 2020, GOLD 2025, the ERS/ATS 2022 and ATS 2023 lung-function statements, and the air-quality guidance: Asthma Control Test, inhaler technique, adherence and reliever use, exacerbation history, exposure review, smoking status, the action plan, and step assessment at every visit; spirometry and FeNO at diagnosis and three months; DLCO, alpha-1 antitrypsin, and imaging once; the six-minute walk before and after rehabilitation; comorbidity screening at diagnosis; vaccination status; and biologic candidacy recorded as not indicated. Two deviations are recorded as `deferred`, with outcome and corrective action, and no result was invented: the review within one week after the flare did not take place (no harm; peak flow recovered by the fifth day without prednisolone; the clinic now books a review within a week, by telephone if needed, written into the care plan as INT-009); and the twelve-week plan set the next full review after adding tiotropium at four months, beyond the protocol's 1 to 3 months; the preventive visit at 13 weeks reviewed his asthma but recorded no Asthma Control Test (no harm; well controlled; a control test is now recorded at any visit where asthma is reviewed).
- **Consultation.** The pulmonology referral and consultation (Ambrose Nwankwo-Fairfax, MD, a fictional consultant, on the day of the second visit) are **S**. The consultant confirms asthma with persistent airflow limitation rather than COPD, finds the CT indicated and shows its findings, recommends medium-dose budesonide-formoterol maintenance and reliever with add-on tiotropium if not controlled at three months, pulmonary rehabilitation, and the exposure plan; the record then shows each of these happening.
- **Real people.** Sydenham, Ashley (Shaftesbury), Lady Masham, Limborch, Boyle, Clarke, Somers, Peter King, Le Clerc, and Isaac Newton appear only in documented history claims. The modern episode names none of them and attributes no decision, statement, or health fact to them; the household he lives with and the friend he names as his health care agent are unnamed and synthetic. The family history of consumption in his father and brother is documented (CLM-0003) and is used only as family history.
- **Primary clinician.** Prudence Hartwell-Osei, MD, is cast as his primary care physician.
- John Locke died in 1704, so the recent-death review rule does not apply. Ordinary clinical, provenance, and safe-messaging reviews remain required.
